Vascular Risk Factors of Hippocampal Subfield Volumes in Persons without Dementia: The Medea 7T Study.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 15 9 2020
medline: 10 9 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Vascular risk factors have been associated with risk of Alzheimer's disease (AD) and volume loss of the hippocampus, but the associations with subfields of the hippocampus are understudied. Knowing if vascular risk factors contribute to hippocampal subfield atrophy may improve our understanding of vascular contributions to neurodegenerative diseases. To investigate the associations between age, sex, and vascular risk factors with hippocampal subfields volumes on 7T MRI in older persons without dementia. From the Medea 7T study, 283 participants (67±9 years, 68% men) without dementia had 7T brain MRI and hippocampal subfield segmentation. Subfields were automatically segmented on the 3D T2-weighted 7T images with ASHS software. Using linear mixed models, we estimated adjusted associations of age, sex, and vascular risk factors with z-scores of volumes of the entorhinal cortex (ERC), subiculum (SUB), Cornu Ammonis (CA)1, CA2, CA3, CA4, and dentate gyrus (DG), and tail as multivariate correlated outcomes. Increasing age was associated with smaller volumes in all subfields, except CA4/DG. Current smoking was associated with smaller ERC and SUB volumes; moderate alcohol use with smaller CA1 and CA4/DG, obesity with smaller volumes of ERC, SUB, CA2, CA3, and tail; and diabetes mellitus with smaller SUB volume. Sex, former smoking, and hypertension were not associated with subfield volumes. When formally tested, no risk factor affected the subfield volumes differentially. Several vascular risk factors were associated with smaller volumes of specific hippocampal subfields. However, no statistical evidence was found that subfields were differentially affected by these risk factors.

Sections du résumé

BACKGROUND
Vascular risk factors have been associated with risk of Alzheimer's disease (AD) and volume loss of the hippocampus, but the associations with subfields of the hippocampus are understudied. Knowing if vascular risk factors contribute to hippocampal subfield atrophy may improve our understanding of vascular contributions to neurodegenerative diseases.
OBJECTIVE
To investigate the associations between age, sex, and vascular risk factors with hippocampal subfields volumes on 7T MRI in older persons without dementia.
METHODS
From the Medea 7T study, 283 participants (67±9 years, 68% men) without dementia had 7T brain MRI and hippocampal subfield segmentation. Subfields were automatically segmented on the 3D T2-weighted 7T images with ASHS software. Using linear mixed models, we estimated adjusted associations of age, sex, and vascular risk factors with z-scores of volumes of the entorhinal cortex (ERC), subiculum (SUB), Cornu Ammonis (CA)1, CA2, CA3, CA4, and dentate gyrus (DG), and tail as multivariate correlated outcomes.
RESULTS
Increasing age was associated with smaller volumes in all subfields, except CA4/DG. Current smoking was associated with smaller ERC and SUB volumes; moderate alcohol use with smaller CA1 and CA4/DG, obesity with smaller volumes of ERC, SUB, CA2, CA3, and tail; and diabetes mellitus with smaller SUB volume. Sex, former smoking, and hypertension were not associated with subfield volumes. When formally tested, no risk factor affected the subfield volumes differentially.
CONCLUSION
Several vascular risk factors were associated with smaller volumes of specific hippocampal subfields. However, no statistical evidence was found that subfields were differentially affected by these risk factors.

Identifiants

pubmed: 32925029
pii: JAD200159
doi: 10.3233/JAD-200159
pmc: PMC7683058
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1223-1239

Références

Int J Neuropsychopharmacol. 2016 Sep 21;19(9):
pubmed: 27207916
Hum Brain Mapp. 2012 Oct;33(10):2377-89
pubmed: 21898677
Front Aging Neurosci. 2014 Sep 25;6:261
pubmed: 25309437
Hum Brain Mapp. 2015 Jan;36(1):258-87
pubmed: 25181316
Am J Psychiatry. 2010 Nov;167(11):1399-406
pubmed: 20686185
Neurology. 2014 Feb 25;82(8):691-7
pubmed: 24453080
Neurosci Biobehav Rev. 2017 Aug;79:66-86
pubmed: 28476525
Nat Rev Neurosci. 2015 Nov;16(11):660-71
pubmed: 26462756
Hum Brain Mapp. 2014 Aug;35(8):3903-18
pubmed: 24453132
Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45
pubmed: 24924665
Neuroimage. 2017 Dec;163:296-300
pubmed: 28917699
Lancet. 1994 Sep 17;344(8925):769-72
pubmed: 7916070
Neuroimage. 2010 Nov 1;53(2):506-14
pubmed: 20600996
Nat Rev Neurosci. 2011 Sep 07;12(10):585-601
pubmed: 21897434
Hippocampus. 2009 Jun;19(6):558-64
pubmed: 19405132
Psychiatry Res. 2007 Jul 15;155(2):155-65
pubmed: 17493789
Brain Struct Funct. 2015 Sep;220(5):2663-74
pubmed: 24947882
Chin Med J (Engl). 2015 Feb 20;128(4):465-71
pubmed: 25673447
Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):17-27
pubmed: 22343374
Drug Alcohol Depend. 2013 Dec 1;133(2):704-11
pubmed: 24051060
Hum Brain Mapp. 2015 Feb;36(2):463-74
pubmed: 25231681
Hum Brain Mapp. 2013 Nov;34(11):3075-85
pubmed: 22815197
Neuroimage. 2012 Jul 16;61(4):1043-9
pubmed: 22440643
Brain Behav. 2019 Aug;9(8):e01351
pubmed: 31240857
Neuroimage. 2016 Feb 15;127:186-195
pubmed: 26679328
Neurobiol Aging. 2012 Jul;33(7):1168-76
pubmed: 21459484
Hippocampus. 2017 May;27(5):481-494
pubmed: 28188659
Neurobiol Aging. 2017 Nov;59:121-134
pubmed: 28886957
Brain. 2008 Dec;131(Pt 12):3266-76
pubmed: 18988639
Ageing Res Rev. 2016 Sep;30:25-48
pubmed: 26827786
Alzheimers Dement. 2017 Apr;13(4):406-418
pubmed: 27599208
Neurobiol Aging. 2001 Sep-Oct;22(5):737-45
pubmed: 11705633
AJNR Am J Neuroradiol. 2016 Jun;37(6):1050-7
pubmed: 26846925
Front Aging Neurosci. 2011 Feb 04;3:2
pubmed: 21331174
Hippocampus. 2016 Feb;26(2):220-8
pubmed: 26286891
Psychiatry Res Neuroimaging. 2016 Dec 30;258:16-22
pubmed: 27829188
Neuroimage. 2018 Feb 1;166:71-78
pubmed: 29107121
Neuroimage. 2015 May 1;111:526-41
pubmed: 25596463
Neurobiol Aging. 2014 Sep;35(9):2039-45
pubmed: 24684788
J Cogn Neurosci. 2013 Nov;25(11):1851-62
pubmed: 23767922
Neurobiol Aging. 2007 May;28(5):719-26
pubmed: 16713659
Neuroimage. 2010 Jan 15;49(2):1224-30
pubmed: 19786104
Nat Rev Neurol. 2012 Mar 13;8(4):189-202
pubmed: 22410582
Cereb Cortex. 1998 Dec;8(8):710-8
pubmed: 9863698
Neuroimage. 2008 Aug 1;42(1):42-8
pubmed: 18534867
Neuroimage Clin. 2019;22:101764
pubmed: 30904825
Neurobiol Aging. 2019 Sep;81:146-156
pubmed: 31280118
Eur Radiol. 2018 Sep;28(9):3811-3818
pubmed: 29619516
Neurobiol Aging. 2020 Jun;90:75-83
pubmed: 32107063
Ann Neurol. 2008 Dec;64(6):698-706
pubmed: 19107993

Auteurs

Kim Blom (K)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Huiberdina L Koek (HL)

Department of Geriatrics, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Maarten H T Zwartbol (MHT)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Rashid Ghaznawi (R)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Hugo J Kuijf (HJ)

Image Sciences Institute, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Theo D Witkamp (TD)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Jeroen Hendrikse (J)

Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Geert Jan Biessels (GJ)

Department of Neurology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Mirjam I Geerlings (MI)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH